Healthcare Services

Global Biopharmaceutical CMO Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Biopharmaceutical CMO Market By 2030 Starting From Its 2026 Size?

The biopharmaceutical cmo market has experienced rapid growth in its size over recent years. It is projected to expand from $28.02 billion in 2025 to $32.03 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.3%. This historic expansion can be linked to increasing biologics pipeline development, expansion of clinical trial activity, a rising demand for flexible manufacturing capacity, the growth of biosimilar approvals, and the availability of specialized biomanufacturing expertise.

The biopharmaceutical CMO market size is anticipated to undergo substantial growth over the next few years. It is projected to expand to $54.54 billion by 2030, achieving a compound annual growth rate (CAGR) of 14.2%. The expansion throughout the forecast period is attributable to several factors, including increased investments in cutting-edge biologics, a surging need for accelerated scale-up manufacturing, the proliferation of personalized therapies, the increasing adoption of continuous bioprocessing, and a greater emphasis on risk-sharing manufacturing models. Noteworthy trends for the forecast period comprise an increase in the outsourcing of biologics manufacturing, a rising call for biosimilar production services, the growing application of single-use bioprocessing systems, the expansion of cell and gene therapy manufacturing, and an enhanced concentration on comprehensive CMO capabilities.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7771&type=smp

What Primary Drivers Are Shaping The Development Of The Biopharmaceutical CMO Market?

The increasing prevalence of chronic diseases is set to drive the expansion of the biopharmaceutical CMO market in the future. These long-term health conditions persist throughout an individual’s life, often progressing slowly and requiring continuous medical attention. Biopharmaceutical CMOs are instrumental in addressing chronic diseases by accelerating the development of drugs, providing cost-effective manufacturing solutions, and upholding high-quality benchmarks, thereby making life-saving medications more accessible and affordable. As an illustration, in January 2024, the World Health Organization, a Switzerland-based intergovernmental body, reported that the burden of noncommunicable diseases, including cardiovascular disease, cancer, chronic respiratory disease, and diabetes, continues to grow. These diseases are responsible for 41 million deaths every year, representing 74% of all deaths and the majority of premature mortality globally, with the most significant consequences observed in low- and middle-income countries. Hence, the rising burden of chronic diseases is a key driver for the biopharmaceutical CMOs market.

Which Segment Categories Define The Biopharmaceutical CMO Market?

The biopharmaceutical cmo market covered in this report is segmented –

1) By Product: Biologics, Biosimilars

2) By Source: Mammalian, Non-Mammalian

3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging

Subsegments:

1) By Biologics: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell And Gene Therapies

2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Recombinant Proteins, Biosimilar Insulins, Biosimilar Growth Hormones

Which Trends Are Influencing The Biopharmaceutical CMO Market?

Leading entities within the biopharmaceutical CMO market are increasingly engaging in strategic collaborations to advance the creation of novel biopharmaceutical offerings. Such alliances prove beneficial for biopharmaceutical CMO organizations by facilitating the pooling of assets and specialized knowledge, thereby boosting research and development capacities, broadening market presence, and hastening product commercialization. This ultimately propels innovation and expansion across the biopharmaceutical CMO sector. An illustrative example occurred in May 2024, when BioConnection, a Netherlands-based contract manufacturing company, formed a partnership with AGC Biologics, a US-based contract development and manufacturing company. Through this collaboration, their objective is to offer an integrated and efficient solution for biopharmaceutical development and manufacturing, thereby shortening project durations and streamlining procedures for drug innovators.

Who Are The Top Companies Competing In The Biopharmaceutical CMO Market?

Major companies operating in the biopharmaceutical cmo market are Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, Evonik Industries AG

Read the full biopharmaceutical cmo market report here:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

How Does The Biopharmaceutical CMO Market Perform Across Major Global Regions?

North America was the largest region in the biopharmaceutical CMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biopharmaceutical CMO Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7771&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical CMO Market 2026, By The Business Research Company

Biopharmaceuticals Contract Manufacturing Global Market Report

https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

Lyophilization Services For Biopharmaceuticals Global Market Report

https://www.thebusinessresearchcompany.com/report/lyophilization-services-for-biopharmaceuticals-global-market-report

Biopharmaceutical Third Party Logistics Global Market Report

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795